Palo Alto, CA, United States of America

Robbie G Majzner

This inventor holds 1 USPTO granted patent and 9 published patent applications. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robbie G Majzner. Retrieved from https://idiyas.com/inventor/robbie-g-majzner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Robbie G Majzner: Innovator in Chimeric Antigen Receptors

Introduction

Robbie G Majzner is a notable inventor based in Palo Alto, CA. He has made significant contributions to the field of immunotherapy, particularly through his work on chimeric antigen receptors.

Latest Patents

Majzner holds a patent for "Chimeric Antigen Receptors Targeting Glypican-2." This innovative approach aims to enhance the effectiveness of targeted therapies in treating various cancers.

Career Highlights

He is currently employed by the United States of America, as Represented by the Secretary, Department of Health and Human Services. His work focuses on advancing therapeutic strategies that leverage the immune system to combat cancer.

Collaborations

Majzner collaborates with esteemed colleagues, including Sabine Heitzeneder and Crystal L Mackall, to further research and development in the field of cancer immunotherapy.

Conclusion

Robbie G Majzner's contributions to the development of chimeric antigen receptors represent a significant advancement in cancer treatment. His innovative work continues to inspire progress in the field of immunotherapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…